Oropharyngeal Cancers Active Not Recruiting Phase 2 Trials for Utomilumab (DB15113)

Also known as: Oropharyngeal Cancer / Cancer of Oropharnyx

IndicationStatusPhase
DBCOND0042409 (Oropharyngeal Cancers)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03258008Utomilumab and ISA101b Vaccination in Patients With HPV-16-Positive Incurable Oropharyngeal CancerTreatment